A year-long wearable study of 462 adults finds that a personalized short-sleep threshold — set relative to each person's own typical pattern — better predicts blood pressure and mood effects than the standard six-hour cutoff, and shows that consistency, not just duration, separates resilient short sleepers from vulnerable ones.
A retrospective cohort study of 268 ALS patients published in BMC Medicine found that moderate-to-severe sleep disturbance, measured at diagnosis, was associated with a 2.65-fold higher risk of tracheostomy or death within 36 months.
A new analysis in the Canadian Medical Association Journal concludes that if governments eliminate seasonal clock changes, the health evidence favors permanent standard time over permanent daylight saving time, especially for sleep and mood.
A nationwide analysis of Medicaid claims found a fourfold difference between states in how often children are tested for sleep apnea, with the lowest rates concentrated in non-metro ZIP codes with larger Black and Hispanic populations.
A study of France's nationwide health claims database found narcolepsy drives a sharp, temporary spike in healthcare costs and sick leave around the time of diagnosis, offering one of the clearest real-world pictures yet of the disease's economic and practical burden.
Mosanna Therapeutics reported positive Phase 1 results for MOS118, a nightly nasal spray designed to restore the upper airway's natural reflex against collapse in obstructive sleep apnea, clearing the way for trials in OSA patients.
An umbrella systematic review led by the European Academy of Neurology and MedUni Vienna pooled evidence across seven health endpoints and found chronic insomnia linked to a 26% higher stroke risk, a 28% higher hospitalization risk, and elevated rates of dementia, depression, and suicidal behavior.
